| Item 1. | Security and Issuer |
| (a) | Title of Class of Securities:
Ordinary Shares, NIS 0.01 par value (underlying American Depositary Shares) |
| (b) | Name of Issuer:
SaverOne 2014 Ltd. |
| (c) | Address of Issuer's Principal Executive Offices:
Em Hamoshavot Road 94, POB 3644, Petah Tikva,
ISRAEL
, 4970602. |
Item 1 Comment:
This Schedule 13D relates to the ordinary shares, NIS 0.01 par value (the "Ordinary Shares"), of SaverOne 2014 Ltd., an Israeli company (the "Issuer"), whose American Depositary Shares trade on The Nasdaq Stock Market LLC under the symbol "SVRE." The principal executive offices of the Issuer are located at Em Hamoshavot Road 94, POB 3644, Petah Tikva, 4970602, Israel. |
| Item 2. | Identity and Background |
|
| (a) | The name of the person filing this statement is VisionWave Holdings, Inc., a Delaware corporation ("VisionWave" or the "Reporting Person"). |
| (b) | The principal business address of VisionWave is 300 Delaware Ave., Suite 210 # 301, Wilmington, DE 19801; (302) 305-4790. |
| (c) | VisionWave is a Nasdaq-listed holding company engaged in developing dual-market autonomous systems platform company developing AI-driven, RF-based sensing, autonomy, and computational acceleration technologies for defense, homeland security, and commercial infrastructure applications. VisionWave's mission is to connect defense innovation with civilian progress through shared core technologies deployed across air, land, and sea. |
| (d) | During the last five years, VisionWave has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) nor been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction resulting in a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. |
| (e) | During the last five years, VisionWave has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) nor been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction resulting in a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. |
| (f) | Delaware, United States. |
| Item 3. | Source and Amount of Funds or Other Consideration |
| | In addition to the acquisitions described in the Original Schedule 13D and Amendment No. 1 and 2, 3, 4, 5 & 6 between March 30, 2026 and June 26, 2026, the Reporting Person acquired an aggregate of 181,055 American Depositary Shares ("ADSs") of the Issuer in open-market transactions on The Nasdaq Stock Market LLC for an aggregate purchase price of approximately $644,491 (exclusive of commissions). On June 26, 2026 per closing of stages based on Exchange Agreement dated January 26, 2026 the Issuer issued additional 16,608,240,000 shares represent 348,450 ADSs at cost of $6.93 per ADS. Each ADS represents 43,200 Ordinary Shares pursuant to the ADS ratio effective February 25, 2026. These transactions resulted in the acquisition of 7,821,576,000 (in the open market) and additional 16,608,240,000 per the Ordinary Shares Exchange Agreement dated January 26, 2026. The funds used for these purchases were from the Reporting Person's working capital. |
| Item 4. | Purpose of Transaction |
| | The additional acquisitions described in Item 3 above were made for investment and strategic purposes consistent with those described in the Original Schedule 13D and Amendments No. 1,2,3,4,5 & 6. The Reporting Person may from time to time acquire additional Ordinary Shares or ADSs of the Issuer in the open market or in privately negotiated transactions, subject to market conditions, applicable securities laws, and other considerations. Except as described herein or in the Original Schedule 13D and Amendment No. 1, the Reporting Person has no current plans or proposals that relate to or would result in any of the actions specified in clauses (a) through (j) of Item 4 of Schedule 13D. |
| Item 5. | Interest in Securities of the Issuer |
| (a) | See Rows 7-13 of the cover page. |
| (b) | See Rows 7-13 of the cover page. |
| (c) | Except for the acquisition described in Item 3, the Reporting Person has not effected any transactions in the Ordinary Shares during the past 60 days. |
| (d) | Not applicable. |
| (e) | Not applicable. |
| Item 6. | Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer |
| | Pursuant to the Exchange Agreement, VisionWave has certain rights including potential board designation rights and milestone-based additional acquisitions. The Exchange Agreement is filed as Exhibit 1 hereto and is incorporated by reference. |
| Item 7. | Material to be Filed as Exhibits. |
| | Exhibit 1: Exchange Agreement dated January 26, 2026, between VisionWave Holdings Inc. and SaverOne 2014 Ltd. (incorporated by reference to relevant SaverOne Form 6-K or as an attachment). |
